Obermatt
See Similar Stocks →

Delcath Systems

NAQ:DCTH · US24661P8077
Health Care Equipment & SuppliesSmall

360

34
Profit price100
Owner Earnings Yield1
Dividend Yield1
Price/Sales38
EV / Gross Profit47
Price/Book34
Return on Capital51
Cash Return on Capital62
Return on Equity65
EBIT Margin51
Gross Profitability76
Cash Conversion100
Accruals87
Owner Earnings Margin62
Sales growth78
Profit Growth40
Long-Term EPS Growth5
Owner Earnings Growth1
Reinvestment80
Price momentum29
Debt load100
Refinancing55
Debt Payback1
Liquidity1
Analyst ratings68
Opinion Changes50
Price Target Upside78
Market mood81
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Delcath Systems doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded1988
Employees126
Websitedelcath.com
ISINUS24661P8077
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
HepatologyOncologyBiotechnologyHealth CarePharmaceutical

Description

Delcath Systems, Inc. (Delcath), an interventional oncology company, focuses on the treatment of primary and metastatic cancers to the liver. The company’s lead product, the HEPZATO KIT (melphalan for Injection/Hepatic Delivery System), a drug/devic…

Analysis

Quality compounder

Delcath Systems, Inc. is a quality compounder: a well-run business trading at a price that reflects what it is worth.

Valuation data is not available for this company.

The trajectory is tepid and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
88
2026

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
38
—
—
—
Price/Earnings
79
—
—
—
Price/Book
34
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
42
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Delcath Systems with its peers
Integer
NYQ:ITGR
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Heartbeam
NAQ:BEAT
10
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Cerus
NMQ:CERS
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Becton Dickinson
NYQ:BDX
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →